Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.7B |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$505M |
| 3 |
Johnson & Johnson
JNJ
|
+$441M |
| 4 |
Mastercard
MA
|
+$406M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$394M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
NVIDIA
NVDA
|
+$1.42B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$907M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$716M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.3% |
| 2 | Financials | 8.57% |
| 3 | Healthcare | 7.58% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAND
3976
Gladstone Land Corp
LAND
$360M
| $2.38M | ﹤0.01% |
171,204
+45,029
| +36% | +$634K |
|
3977
Seneca Foods Class A
SENEA
$1.13B
| $2.37M | ﹤0.01% |
38,076
+9,000
| +31% | +$545K |
|
3978
PUT
Abbott
ABT
$187B
| $2.37M | ﹤0.01% |
20,800
-17,400
| -46% | -$1.91M |
|
|
ACB
3979
Aurora Cannabis
ACB
$185M
| $2.37M | ﹤0.01% |
402,814
+304,953
| +312% | +$1.81M |
|
3980
Bank First Corp
BFC
$1.72B
| $2.36M | ﹤0.01% |
26,061
+16,030
| +160% | +$1.42M |
|
3981
Oil-Dri
ODC
$1.4B
| $2.36M | ﹤0.01% |
68,456
+7,572
| +12% | +$247K |
|
3982
PUT
Darling Ingredients
DAR
$9.62B
| $2.36M | ﹤0.01% |
+63,500
| New | +$2.39M |
|
3983
Varex Imaging
VREX
$516M
| $2.36M | ﹤0.01% |
197,851
-76,625
| -28% | -$976K |
|
3984
Copel
ELPC
$8.6B
| $2.36M | ﹤0.01% |
376,984
-16,751
| -4% | -$110K |
|
3985
Daily Journal
DJCO
$795M
| $2.36M | ﹤0.01% |
4,806
+1,468
| +44% | +$667K |
|
3986
Equity Bancshares
EQBK
$1.05B
| $2.35M | ﹤0.01% |
57,593
+24,412
| +74% | +$951K |
|
3987
CALL
Vanguard Information Technology ETF
VGT
$147B
| $2.35M | ﹤0.01% |
32,000
+8,000
| +33% | +$569K |
|
3988
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$760M
| $2.34M | ﹤0.01% |
+30,952
| New | +$2.21M |
|
|
INST
3989
DELISTED
Instructure Holdings, Inc.
INST
| $2.34M | ﹤0.01% |
99,417
-59,112
| -37% | -$1.4M |
|
|
INZY
3990
DELISTED
Inozyme Pharma
INZY
| $2.34M | ﹤0.01% |
447,317
+85,449
| +24% | +$444K |
|
3991
Theravance Biopharma
TBPH
$877M
| $2.34M | ﹤0.01% |
289,789
-43,762
| -13% | -$379K |
|
3992
Zentalis Pharmaceuticals
ZNTL
$356M
| $2.33M | ﹤0.01% |
634,064
+14,811
| +2% | +$53.8K |
|
3993
CALL
Regions Financial
RF
$26.8B
| $2.33M | ﹤0.01% |
100,000
| – | – |
|
|
3994
PUT
Regions Financial
RF
$26.8B
| $2.33M | ﹤0.01% |
100,000
| – | – |
|
3995
BBVA Argentina
BBAR
$3.56B
| $2.33M | ﹤0.01% |
224,704
+141,009
| +168% | +$1.38M |
|
3996
CALL
Johnson Controls International
JCI
$93.6B
| $2.33M | ﹤0.01% |
30,000
-40,500
| -57% | -$2.84M |
|
3997
ATN International
ATNI
$471M
| $2.33M | ﹤0.01% |
71,931
-8,336
| -10% | -$219K |
|
3998
LSB Industries
LXU
$698M
| $2.32M | ﹤0.01% |
288,985
-97,628
| -25% | -$775K |
|
3999
Nektar Therapeutics
NKTR
$2.48B
| $2.32M | ﹤0.01% |
118,896
+1,063
| +0.9% | +$20.3K |
|
4000
Silicon Motion
SIMO
$9.07B
| $2.31M | ﹤0.01% |
38,076
-73,999
| -66% | -$4.88M |
|
Similar funds
Goldman Sachs's Q3 2024 Portfolio in Review
As of Q3 2024, Goldman Sachs held 6,216 positions worth $621B, up 5% from $591B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q3 2024 filing shows 596 new, 2,752 increased, 1,995 reduced and 427 closed positions. Its largest new stake was Smurfit Westrock: 3,644,566 shares worth $180M. The largest sale was Tesla, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2024 buy was Smurfit Westrock: 3,644,566 shares worth $180M.
- Goldman Sachs added most to TC Energy in Q3 2024, an estimated $1.7B increase.
- Goldman Sachs's biggest Q3 2024 reduction was Tesla, cutting an estimated $1.61B.
- Goldman Sachs fully exited WestRock Company in Q3 2024, selling an estimated $204M.
- Goldman Sachs's ten largest holdings make up 19% of its $621B portfolio in Q3 2024.
- Goldman Sachs opened 596 new positions and closed 427 in Q3 2024.
- Goldman Sachs's portfolio value rose 5% quarter-over-quarter to $621B.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.